Obesity medicines are showing us a black hole in healthcare systems when it comes to overcoming the cascade of chronic diseases that result from leaving it untreated. HT: @bostonglobe.com conscienhealth.org/2026/07/20/e...

At #ICO2026 on Obesity in Mexico City last week, we saw evidence for a meaningful shift toward a growing voice on a global scale for people living with obesity. conscienhealth.org/2026/07/19/t...

An important new study offers a much insight into how obesity may actively promote the progression of certain leukemias. conscienhealth.org/2026/07/18/r...

Keeping the pot stirred, @amdiabetesassn.bsky.social has quashed publication of a series of papers about what transpired at the ADA Scientific Sessions, with police called to eject top scientists from the meeting. Transparency? Integrity? Not apparent. conscienhealth.org/2026/07/17/d...

"Spectacularly false noise is becoming a familiar feature of health discourse." "Spectacularly false" a great phrase. Gonna start using! And it applies to lies about vaccines, diets, detoxes, supplements, longevity, etc etc etc conscienhealth.org/2026/07/16/t... by @conscienhealth.bsky.social 🙏

“Spectacularly false” health noise seems to be at an all time high. It's exhausting, but patient persistence can help truth prevail. HT: @marionnestle.bsky.social conscienhealth.org/2026/07/16/t...

An excellent new study reminds us that getting too little sleep can nudge body weight upward in surprisingly little time. More importantly, it reminds us of a basic truth that often gets lost in discourse about obesity: This disease is multifactorial. conscienhealth.org/2026/07/15/l...

Why does the diagnosis of obesity cause such dissonance? Why do some really smart people make it so hard? Here's a clue: Bias for neglecting the lived experiences of people with obesity. conscienhealth.org/2026/07/14/d...

Are the crystal clear frozen ice cubes at Aldi (4 for $5) emblematic of our dysfunctional global food systems? Deeply troubling? Ultra-processed to make them unnaturally sparkling clear? A nefarious subversion from Big Food? conscienhealth.org/2026/07/13/a...

Headlines from @bmj.com tell us most obesity medicines don't improve quality of life. Trouble is, the "systematic review" generating these headlines largely excluded real studies of quality of life. conscienhealth.org/2026/07/12/q...

When Serena Williams returned to Wimbledon this year, she brought more than one of the greatest tennis careers in history back onto Centre Court. She also brought a fresh round of public anxiety about GLP-1 medicines. conscienhealth.org/2026/07/11/m...

Conversations about medical care for obesity and cultural pressures for thinness are distinctly different, but they wind up intersecting and making rational discourse exceedingly difficult. conscienhealth.org/2026/07/10/g...

New research helps to explain how fine particulate air pollution can contribute to the development of obesity in childhood. Yes, it's more than the food environment that is giving us a rise in obesity. conscienhealth.org/2026/07/09/u...

Shocked! People are expressing surprise that 11% of U.S. adults are using a GLP-1. Frankly, we're surprised the number is not higher because the need is great. HT: @gallup.com conscienhealth.org/2026/07/08/s...

When @jama.com tells us people are getting GLP-1s online with little medical help, our response is "duh!" Where is the medical help? Not in the systemic bias and denial of care embodied by health systems. conscienhealth.org/2026/07/07/d...

Works fine for industrial food manufacturer's as long as the industry controls the definition so nutrient marketing continues to be good for business.

With @hhsofficial.bsky.social and RFK Jr. telling us simply to "eat more protein," it's a good time to take a look at what science says about such broad dietary advice. conscienhealth.org/2026/07/06/h...

Yes, the Medicare Bridge Program is a big deal. But will it overcome stigma, transform the economy, and bring us good health all at once? @vox.com is setting some high expectations for a post-GLP-1 era in America. conscienhealth.org/2026/07/05/r...

Caution warranted for interpreting an important new study in @thelancet.com. Managing CV risk factors is no substitute for obesity care. Necessary, but not sufficient. conscienhealth.org/2026/07/04/i...

"Dietary guidance based solely on the HPFB concept is, presently, not in the public's best interest." So says a new review of the relevant science, published by the Advances in Nutrition journal. Dissonance abounds on UPFs, as does confident rectitude. conscienhealth.org/2026/07/03/h...

Today, thanks to tireless work of @obesityaction.bsky.social Action, Joe Nadglowski, and many others, we can celebrate a big step forward in access to care. conscienhealth.org/2026/07/02/o...

The @amdiabetesassn.bsky.social has a stain on its reputation that is obvious, but as many distinguished scientists and journals have noted, that stain will not fade until the ADA admits and corrects its errors. conscienhealth.org/2026/07/01/a...

When people start labeling GLP-1s as longevity medicines, hold on to your wallet. Obesity medicine professionals have always a goal to help people live longer and better. Marketing hype from longevity medicine entrepreneurs adds nothing to that. conscienhealth.org/2026/06/29/o...

News and social media have become oddly fascinated with a provocative question: Who got compassionate use access to retatrutide from @elilillyandcompany.bsky.social? They're chasing the wrong question. conscienhealth.org/2026/06/29/w...

In @nature.com Medicine, Tim Garvey says we should move the goalposts for obesity drug development. He’s right. But the goalposts have already moved. conscienhealth.org/2026/06/28/t...

If you want to take a discerning view of the new @americanheart.bsky.social scientific statement on exercise in obesity treatment, you'll want to listen up to John Jakicic and Renee Rogers. It's time to focus on health outcomes. conscienhealth.org/2026/06/27/i...

A new editorial in @jama.com raises good questions about the Medicare Bridge program. Questions to prompt consideration and study, not excuses for continued neglect of obesity care. conscienhealth.org/2026/06/26/e...

Every so often, life reminds us that productivity alone does not guarantee well-being. This is one of those times. So we're asking you for grace to give us some space for healing. conscienhealth.org/2026/06/25/n...

As employers and health plans struggle with the cost of GLP-1 medicines, a new industry has emerged with a compelling sales pitch: We can help you reduce spending on obesity treatment. But many of them are just rationalizing denial of care. conscienhealth.org/2026/06/24/d...

New research in Obesity tells even as the need grows, surgical care for people with severe obesity is becoming less available. Systemic bias often puts it out of reach. conscienhealth.org/2026/06/23/w...

New research in @plos.org Genetics shines a light on the interaction of genes and environment in obesity. It turns out that genetics have grown more important in our increasingly obesogenic environment. conscienhealth.org/2026/06/22/t...

Political efforts to "tackle" obesity are often quick to claim success and slow to help people affected by it. RFK Jr. gave us a case in point this week. HT: @foodfixco.bsky.social conscienhealth.org/2026/06/21/t...

Less than half of Americans can afford the healthcare they need, says @gallup.com this week. So is it any wonder that access to obesity care is so poor? conscienhealth.org/2026/06/20/w...

Why did so many experts and analysts fail to anticipate the roaring success of #Wegovy tablets? Perhaps because they discounted the importance of human factors. They are not a footnote in obesity care. They are often the deciding factor. @novonordisk.bsky.social conscienhealth.org/2026/06/19/w...

A rising tide of science suggests obesity medicines might have a surprising benefit: a reduction in the risk of obesity-related cancers. Annals of Oncology puts this in the spotlight with a striking new study. conscienhealth.org/2026/06/18/r...

Headlines are spinning out the story that lifestyle change is the "winning strategy" for preventing diabetes. A closer look tells us this narrative glosses over important factors in real life. HT: @jama.com conscienhealth.org/2026/06/17/t...

An abstract from #ENDO2026 drew a press release to suggest GLP-1s make people exercise less. This observed association should prompt curiosity, not activate implicit bias against obesity treatment as a "lazy way out." Correlation ≠ Causality. conscienhealth.org/2026/06/16/i...

Human data on the effects of #LinoleicAcid brings us to question the assumption that it fuels #inflammation. Science advances by testing hypotheses against observations, not by defending them forever. conscienhealth.org/2026/06/15/i...

With a sorry-not-sorry apology in the rear view mirror, how much does it still matter that @amdiabetesassn.bsky.social called the cops on their top scientists and admit no mistake in that? Dr Arya Sharma offers perspective today on ConscienHealth. conscienhealth.org/2026/06/14/w...

For true believers in food labeling to cure our ills with obesity, @thelancet.com has a study for you. Labeling fans see "plausible" evidence for an effect on obesity prevalence in Chile. conscienhealth.org/2026/06/13/b...

All generalizations are dangerous. Including generalizations about ultra-processed foods. A new analysis in @science.org Magazine offers caution about the "war" on ultra-processed foods we are marching toward. conscienhealth.org/2026/06/12/d...

Will an apology for "events that occurred" without owning the mistake of calling out police against your most respected scientists make this "moral stain" on the @amdiabetesassn.bsky.social go away? We have our doubts. conscienhealth.org/2026/06/11/a...

The big winner at #ADASciSessions seems to be @elilillyandcompany.bsky.social with #retatrutide. Yes, it delivers remarkable weight loss outcomes. But unlocking the meaning of these results in clinical care will take some time. conscienhealth.org/2026/06/10/a...

As the #ADASciSessions came to a close in New Orleans, it became clear that obesity medicines are entering a new phase of growth. conscienhealth.org/2026/06/09/a...

Controversy swirling around ADA leadership at the #ADASciSessions deepened today as the President-Elect and Scientific Sessions Planning Committee Chair resigned. conscienhealth.org/2026/06/08/a...

Survodutide, a dual GLP-1/glucagon agonist grabbed the spotlight at #ADASciSessions yesterday with evidence that it has metabolic benefits in obesity beyond weight loss. conscienhealth.org/2026/06/08/a...

At the #ADASciSessions, it is clear that injecting politics into science has proven to be a terrible distraction. conscienhealth.org/2026/06/07/a...